[Predictive factors of the therapeutic result in the prevention of auricular fibrillation. Role of electrophysiological studies].
A population of 50 patients suffering from paroxysmal attacks of atrial fibrillation was studied prospectively to evaluate the prognostic value of 20 variables: 6 clinical variables: sex, age, cardiopathy, number of arrhythmic attacks, "vagal" triggering, failure of class IA antiarrhythmic agents; 3 echocardiographic variables: left ventricular diastolic diameter and percentage of fibre shortening, left atrial diameter; 6 basic electrophysiological data: threshold, refractory periods at 110 and 150/min, modalities of induction of a sustained arrhythmia; 4 results observed with an infusion of flecainide in doses of 2 mg/kg: arrest or persistence of the arrhythmia, whether or not it could be reinduced and value of refractory periods; doses of flecainide administered orally. With a mean +/- SD follow-up period of 7.7 +/- 7.3 months, preventive treatment with flecainide 233 +/- 7 mg failed in 16 patients (32 per cent) and succeeded in 34 patients (68 per cent). Analysis of Kaplan-Meier curves and use of Cox's multidimensional model showed that two electrophysiological data were of prognostic value: atrial effective refractory period, and non-inducibility of the arrhythmia after intravenous administration of flecainide. Thus, the probability of failure increases with the refractory period value and decreases with the non-inducibility of the arrhythmia.